Clindamycin is a lincosamide antibiotic. It is usually used to treat infections with anaerobic bacteria, but can also be used to treat some protozoal diseases, such as malaria. It is a common topical treatment for acne and can be useful against some methicillin-resistant Staphylococcus aureus (MRSA) infections.[1] The most severe common adverse effect of clindamycin is Clostridium difficile-associated diarrhea (the most frequent cause of pseudomembranous colitis). Although this side effect occurs with almost all antibiotics, including beta-lactam antibiotics, it is classically linked to clindamycin use.[2] Synonyms: (7S)-7-Chloro-7-deoxylincomycin hydrochloride, (2S-trans)-Methyl 7-Chloro-6,7,8-trideoxy-6[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-L-threo-a-D-galacto-octopyranoside CAS No: 21462-39-5 Molecular Formula: C18H34Cl2N2O5S Molecular Weight: 461.44 Appearance: Supplied as a white powder. Potency: 860ug/mg Water: 5% Storage and Stability: Powder may be stored at -20C. Stable for 6 months at -20C. Hygroscopic. Store under inert atmosphere.
Molekulargewicht:
461.44
CAS Nummer:
[21462-39-5]
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
